ISTANBUL — Turkey is starting clinical trials of potential vaccines for the novel coronavirus, working with drugmakers in China, the United States and other countries.
On Wednesday, three Turkish health workers at an Ankara research hospital began Phase III trials of Chinese manufacturer Sinovac Biotech’s vaccine, Health Minister Fahrettin Koca said at a news conference after a meeting with the government’s coronavirus task force. The trial will eventually be expanded to 10,000 volunteers and the vaccine’s effectiveness in creating antibodies will become clear within a month.